Skip to content

Zoladex 3

DRUG5 trials

Sponsors

UZ Leuven, Grupo Espanol De Investigacion En Cancer De Mama, Astrazeneca AB, Instituto De Investigacion En Oncología Radioterapica FEOR, Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Conditions

Early Breast CancerOligorecurrent hormone-sensitive prostate cancer patientsPatients with ER+ HER2- advanced breast cancer and patients with high-grade serious ovarian cancer (HGSOC)Patients with invasive breast cancer in early stagesProstate Cancer

Phase 1

Phase 3

Phase 4